Abstract
Allelic losses on chromosome 12p12-13 are associated with childhood acute lymphoblastic leukemia (ALL) and several solid neoplasias, suggesting the presence of a tumor suppressor locus. The recent construction of a transcription map of this locus has enabled the identification of eight genes, of which five were previously known: ETV6, BCL-G, LRP6, MKP-7, and CDKN1B. The three other candidate genes, LOH12CR1, LOH12CR2, and LOH12CR3, have no known functions. To evaluate whether one (or more) of the candidate genes is the actual target of the 12p12-13 deletions, we examined the genomics and the expression status of these genes in ALL patients. Although we found nine DNA variants in these genes, no inactivating mutations were found in the leukemia cells of patients with 12p hemizygous deletions. Expression analysis revealed that most 12p hemizygously deleted samples also carried a t(12;21) translocation, of which none expressed ETV6 from the nontranslocated allele. Furthermore, we observed one case of t(12;21) without deletion of ETV6, in which the expression of this gene was greatly reduced, indicating a different mechanism of inactivation. None of the other genes showed a significant decrease in expression, suggesting that ETV6 is indeed the target of deletions in ALL patients.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Stegmaier K, Pendse S, Barker GF, Bray-Ward P, Ward DC, Montgomery KT et al. Frequent loss of heterozygosity at the TEL gene locus in acute lymphoblastic leukemia of childhood. Blood 1995; 86: 38–44.
Takeuchi S, Bartram CR, Miller CW, Reiter A, Seriu T, Zimmerann M et al. Acute lymphoblastic leukemia of childhood: identification of two distinct regions of deletion on the short arm of chromosome 12 in the region of TEL and KIP1. Blood 1996; 87: 3368–3374.
Baccichet A, Sinnett D . Frequent deletion of chromosome 12p12.3 in children with acute lymphoblastic leukaemia. Br J Haematol 1997; 99: 107–114.
Aissani B, Bonan C, Baccichet A, Sinnett D . Childhood acute lymphoblastic leukemia: is there a tumor suppressor gene in chromosome 12p12.3? Leuk Lymphoma 1999; 34: 231–239.
Aissani B, Sinnett D . Fine physical and transcript mapping of a 1.8 Mb region spanning the locus for childhood acute lymphoblastic leukemia on chromosome 12p12.3. Gene 1999; 240: 297–305.
Baens M, Wlodarska I, Corveleyn A, Hoornaert I, Hagemeijer A, Marynen P . A physical, transcript, and deletion map of chromosome region 12p12.3 flanked by ETV6 and CDKN1B: hypermethylation of the LRP6 CpG island in two leukemia patients with hemizygous del(12p). Genomics 1999; 56: 40–50.
Montpetit A, Boily G, Sinnett D . A detailed transcriptional map of the chromosome 12p12 tumour suppressor locus. Eur J Hum Genet 2002; 10: 62–71.
Wang LC, Kuo F, Fujiwara Y, Gilliland DG, Golub TR, Orkin SH . Yolk sac angiogenic defect and intra-embryonic apoptosis in mice lacking the Ets-related factor TEL. EMBO J 1997; 16: 4374–4383.
Wang LC, Swat W, Fujiwara Y, Davidson L, Visvader J, Kuo F et al. The TEL/ETV6 gene is required specifically for hematopoiesis in the bone marrow. Genes Dev 1998; 12: 2392–2402.
Rubnitz JE, Pui CH, Downing JR . The role of TEL fusion genes in pediatric leukemias. Leukemia 1999; 13: 6–13.
Shurtleff SA, Buijs A, Behm FG, Rubnitz JE, Raimondi SC, Hancock ML et al. TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia 1995; 9: 1985–1989.
Cave H, Cacheux V, Raynaud S, Brunie G, Bakkus M, Cochaux P et al. ETV6 is the target of chromosome 12p deletions in t(12;21) childhood acute lymphocytic leukemia. Leukemia 1997; 11: 1459–1464.
Guo B, Godzik A, Reed JC . Bcl-G, a novel pro-apoptotic member of the Bcl-2 family. J Biol Chem 2001; 276: 2780–2785.
Tamai K, Semenov M, Kato Y, Spokony R, Liu C, Katsuyama Y et al. LDL-receptor-related proteins in Wnt signal transduction. Nature 2000; 407: 530–535.
Wehrli M, Dougan ST, Caldwell K, O'Keefe L, Schwartz S, Vaizel-Ohayon D et al. Arrow encodes an LDL-receptor-related protein essential for Wingless signalling. Nature 2000; 407: 527–530.
Tanoue T, Yamamoto T, Maeda R, Nishida E . A novel MAPK phosphatase MKP-7 acts preferentially on JNK/SAPK and p38 alpha and beta MAPKs. J Biol Chem 2001; 276: 26629–26639.
Philipp-Staheli J, Payne SR, Kemp CJ . p27(Kip1): regulation and function of a haploinsufficient tumor suppressor and its misregulation in cancer. Exp Cell Res 2001; 264: 148–168.
Stegmaier K, Takeuchi S, Golub TR, Bohlander SK, Bartram CR, Koeffler HP . Mutational analysis of the candidate tumor suppressor genes TEL and KIP1 in childhood acute lymphoblastic leukemia. Cancer Res 1996; 56: 1413–1417.
Baccichet A, Qualman SK, Sinnett D . Allelic loss in childhood acute lymphoblastic leukemia. Leuk Res 1997; 21: 817–823.
Romana SP, Le Coniat M, Poirel H, Marynen P, Bernard O, Berger R . Deletion of the short arm of chromosome 12 is a secondary event in acute lymphoblastic leukemia with t(12;21). Leukemia 1996; 10: 167–170.
Livak KJ, Schmittgen TD . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 2001; 25: 402–408.
Pietenpol JA, Bohlander SK, Sato Y, Papadopoulos N, Liu B, Friedman C et al. Assignment of the human p27Kip1 gene to 12p13 and its analysis in leukemias. Cancer Res 1995; 55: 1206–1210.
Kibel AS, Faith DA, Bova GS, Isaacs WB . Mutational analysis of ETV6 in prostate carcinoma. Prostate 2002; 52: 305–310.
Montpetit A, Boily G, Sinnett D . A detailed transcriptional map of the chromosome 12p12 tumour suppressor locus. Eur J Hum Genet 2002; 10: 62–71.
Fodde R, Smits R . Cancer biology. A matter of dosage. Science 2002; 298: 761–763.
Hoornaert I, Marynen P, Goris J, Sciot R, Baens M . MAPK phosphatase DUSP16/MKP-7, a candidate tumor suppressor for chromosome region 12p12-13, reduces BCR-ABL-induced transformation. Oncogene 2003; 22: 7728–7736.
Fero ML, Randel E, Gurley KE, Roberts JM, Kemp CJ . The murine gene p27Kip1 is haplo-insufficient for tumour suppression. Nature 1998; 396: 177–180.
Song WJ, Sullivan MG, Legare RD, Hutchings S, Tan X, Kufrin D et al. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Nat Genet 1999; 23: 166–175.
Patel N, Goff LK, Clark T, Ford AM, Foot N, Lillington D et al. Expression profile of wild-type ETV6 in childhood acute leukaemia. Br J Haematol 2003; 122: 94–98.
Poirel H, Lacronique V, Mauchauffe M, Le Coniat M, Raffoux E, Daniel MT et al. Analysis of TEL proteins in human leukemias. Oncogene 1998; 16: 2895–2903.
Romana SP, Mauchauffe M, Le Coniat M, Chumakov I, Le Paslier D, Berger R et al. The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion. Blood 1995; 85: 3662–3670.
Latil A, Guerard M, Berthon P, Cussenot O . 12p12-13 deletion in prostate tumors and quantitative expression of CDKN1B and ETV6 candidate genes. Genes Chromosomes Cancer 2001; 31: 199–200.
Ford AM, Bennett CA, Price CM, Bruin MC, Van Wering ER, Greaves M . Fetal origins of the TEL–AML1 fusion gene in identical twins with leukemia. Proc Natl Acad Sci USA 1998; 95: 4584–4588.
Wiemels JL, Ford AM, Van Wering ER, Postma A, Greaves M . Protracted and variable latency of acute lymphoblastic leukemia after TEL–AML1 gene fusion in utero. Blood 1999; 94: 1057–1062.
Andreasson P, Schwaller J, Anastasiadou E, Aster J, Gilliland DG . The expression of ETV6/CBFA2 (TEL/AML1) is not sufficient for the transformation of hematopoietic cell lines in vitro or the induction of hematologic disease in vivo. Cancer Genet Cytogenet 2001; 130: 93–104.
Pine SR, Wiemels JL, Jayabose S, Sandoval C . TEL–AML1 fusion precedes differentiation to pre-B cells in childhood acute lymphoblastic leukemia. Leuk Res 2003; 27: 155–164.
Acknowledgements
This work was supported by the Canadian Institutes of Health Research CIHR (grant number MOP-14108). DS is a scholar of the Fonds de la Recherche en Santé du Québec (FRSQ). AM and GB received studentships from the CIHR and the FRSQ, respectively.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on Leukemia website (http://www.nature.com/leu)
Supplementary information
Rights and permissions
About this article
Cite this article
Montpetit, A., Larose, J., Boily, G. et al. Mutational and expression analysis of the chromosome 12p candidate tumor suppressor genes in pre-B acute lymphoblastic leukemia. Leukemia 18, 1499–1504 (2004). https://doi.org/10.1038/sj.leu.2403441
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403441
Keywords
This article is cited by
-
BCL-G: 20 years of research on a non-typical protein from the BCL-2 family
Cell Death & Differentiation (2023)
-
Haploinsufficiency of ETV6 and CDKN1B in patients with acute myeloid leukemia and complex karyotype
BMC Genomics (2014)
-
Detection of Bcl-2 family member Bcl-G in mouse tissues using new monoclonal antibodies
Cell Death & Disease (2012)
-
Bcl-2 family member Bcl-G is not a proapoptotic protein
Cell Death & Disease (2012)
-
Bcl-G acquitted of murder!
Cell Death & Disease (2012)